key: cord-0822584-ql2sqfs6 authors: Zhang, Yiyan; Guo, Xiaozhong; Ma, Zhuang; Wang, Bing; Lu, Hui; Qi, Xingshun title: Characteristics and In-Hospital Outcomes of COVID-19 Patients with Acute or Subacute Liver Failure date: 2021-05-31 journal: Dig Liver Dis DOI: 10.1016/j.dld.2021.05.027 sha: e8528a7063a91604895ca00502ee27d08af5ba49 doc_id: 822584 cord_uid: ql2sqfs6 nan were diagnosed with or developed ALF/SALF were further identified. Age, gender, underlying diseases, and malignancy were not limited. Exclusion criteria were as follows: 1) patients who were previously diagnosed with liver diseases, including chronic liver disease, cirrhosis, and liver cancer, etc.; and 2) patients who did not undergo liver biochemical examinations at admission and during hospitalization. According to the Chinese guideline regarding management of liver failure 4 A total of six patients were eligible, of whom two and four had ALF and SALF, respectively. The median age was 69 years old and four (66.67%) patients were male. Two patients had hypertension and one had diabetes. At admission, five, one, and four patients presented with fatigue, nausea, and poor appetite, respectively; and three and three patients had severe and critical COVID-19, respectively. None. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request. The authors declare that there is no conflict of interest in this study. COVID 19 and liver: An A-Z literature review. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients a systematic review and meta-analysis Acute liver failure Liver Failure and Artificial Liver Group of Chinese Society of Infectious Diseases, Severe Liver Disease and Artificial Liver Group of Chinese Society of Guideline for diagnosis and treatment of liver failure Figure 1: Dynamic changes of total bilirubin level and international normalized ratio during hospitalization We are indebted to all of the medical staffs who volunteered to participate in the treatment of COVID-19 patients at the Wuhan Huoshenshan Hospital. We would like